Five months from becoming a doctor, Emilio Galán began asking doctors whether he ought to become one. This was an inconvenient time for market research. He had already cleared the exams, spent years in clinical training at UCSF, and narrowed his possible specialties to ENT and urology. He liked patients. He liked the work. Then the people already doing it began describing the life around the work.
During his final year, three attending physicians he looked toward as models quit clinical practice or pulled sharply back. One traded patient care for teaching. Another wanted to see his children instead of coming home from a full clinic day to begin a second shift of paperwork. The third reduced clinical hours. Around Galán, some medical graduates were skipping residency altogether. They called themselves the Dropout Docs, a name with the cheerful menace of a garage band.
Galán had wanted medicine since high school. At Arizona State University, his undergraduate thesis examined how healthcare systems measure performance. In the joint UCSF-UC Berkeley program, he paired clinical training with a master's degree focused on healthcare economics and policy. He had learned to see the exam room and the spreadsheet at once. The trouble was now obvious from either angle: too much of a physician's day belonged to billing, coding, compliance, and the electronic record.
So he left. Not at the beginning, when departure might have looked like a correction, but near the ceremonial end. The white coat was almost his. Galán chose the problem that had spoiled it.
“I was hearing lots of doctors telling me not to practice.”Emilio Galán, describing his final stretch of clinical training
First, learn where the friction lives
Before Robin, there was HonestHealth. Galán worked with claims data and consumer applications, including projects involving Consumer Reports and the New York State Department of Health. Claims are healthcare translated into an administrative dialect: codes, payments, permissions, denials. They are dull only until one notices that they determine what gets paid, what gets measured, and what professionals spend their evenings proving.
That work gave him a view of medicine few students receive. Clinical training teaches what should happen for a patient. Claims show what the system is willing to recognize afterward. Galán could see the gap between those versions of the same visit. A thoughtful conversation might become a thicket of checkboxes; a clinician's judgment might need to be restated in the precise grammar of reimbursement. The visit was brief. Its administrative afterlife was remarkably durable.
The pattern also explained why a prettier electronic record would not be enough. The screen was only the visible surface of rules created by many parties with different incentives. Galán's instinct was to begin earlier, while the clinical encounter was still happening, and capture a richer account before it had been flattened into fields. The exam room, not the billing office, held the original material.
At a health conference, Galán met Noah Auerhahn, an entrepreneur looking for his next company. They looked at the spread of voice assistants in homes and imagined a more demanding assignment. Could a device hear the natural conversation in an exam room and turn it into the documentation required elsewhere? The ambition was not to make the doctor operate another machine. It was to make the machine understand when it should disappear.
Robin's earliest attempts were pleasingly ordinary. A webcam on a physician's computer. Then a tablet tucked into a slot on the counter. Eventually the team built a smooth, egg-shaped object with four microphones and a wide-angle camera. It was less spaceship than well-mannered appliance. Audio and video passed through software models, then through human quality review. The output went where the practice needed it: the medical record, a billing workflow, an insurer.
The company did not arrive at the name casually. Galán and Auerhahn wanted the assistant to be a sidekick. “Robin” carried the comic-book association, but it also worked as both a name and a thing. A clinician could address it without making the room sound as if it had been conquered by enterprise software. The name contained a useful hierarchy. The doctor and patient were the story. Robin belonged one step behind.
Galán could be blunt about what that hierarchy required. Robin was not meant to preserve every habit physicians had developed around documentation. Bloated notes, copied text, and examinations recorded more completely than they had been performed were not sacred merely because they were familiar. He argued that a system built around direct evidence should change the output too. This was the less cuddly meaning of “sidekick”: useful help sometimes refuses to flatter the hero.
A company built around the missing 90 minutes
Robin began in orthopedics and expanded across surgical specialties and primary care. By late 2021, more than 1,000 assistants were in use. The company said patients overwhelmingly agreed to the device's presence. Doctors could speak a short assessment after a visit, while Robin handled the conversion from conversation to structured record. The promise was roughly 90 minutes returned to a physician's day.
The economics grew with the hardware. An $11.5 million Series A in 2019 brought Robin's reported financing to $15 million. In December 2021, Galán announced a $50 million Series B led by Scale Venture Partners. The language of the moment was expansion: more specialties, more rooms, more doctors rescued from what he called “death by a thousand clicks.”
Galán was more colorful when discussing the plumbing. Electronic-record interoperability was, in his phrase, “a giant stinking mess.” Robin used whatever worked: full integrations, automation, file transfers, sometimes manual effort. The elegant device in the room depended on inelegant persistence behind it. AI had not abolished the human layer either. Coders, scribes, and auditors checked the work, sometimes multiple times. In a field where an error could travel from a note into a bill or a later decision, automation had to earn trust line by line.
This made Galán an unusual technology salesman. He was not selling a future in which software became the protagonist. He was selling the restoration of an older social arrangement: one person explaining, another listening, neither required to court a monitor with constant clicks. The novelty lived in the background so the ordinary human exchange could return to the foreground.
His own language rarely sounded engineered for a pitch deck. He compared the administrative layers of American healthcare to descending through Dante's circles, then to falling down Alice's rabbit hole. The mixed literary itinerary was apt. Every attempt to simplify one task seemed to reveal another corridor, another rule, another fax machine inexplicably enjoying its retirement years at full employment.
“We want to support docs.”Galán on why the company chose the name Robin
The second exit
Robin's operating story ended in 2023. Employees publicly announced that the company was going out of business, an abrupt conclusion after the funding, deployments, and promise. Startup narratives prefer a sale, a bell, or a logo sliding neatly beneath a larger logo. Closure is less cooperative. It leaves the useful work and the difficult ending in the same sentence.
Galán's next public chapter did not come with another chief executive title. In January 2026, he appeared on the Startup Dad podcast as a former entrepreneur and a full-time stay-at-home father of two. The episode's title placed him in a “dopamine desert,” the quieter territory after years of startup urgency. He spoke about learning to find satisfaction in ordinary moments, handling the expectations of parenthood, and building a family-first life.
There is an appealing symmetry in this turn. Robin's pitch was time returned: fewer evenings at the keyboard, more attention available for the people waiting beyond it. Galán had been moved by the attending physician who left practice to be with his children. Years later, he made a related choice in his own life. It would be too tidy to claim that one caused the other. It is fair to notice that the same unit of value appears in both stories. Time is not abstract when someone is waiting for you.
His parenting philosophy sounds deliberately unpolished. The podcast describes a “wipe the butt” rule, a comic shorthand for balancing responsibility, firm boundaries, and emotional availability. It is a long way from venture announcements and clinical-documentation architecture. It is also the kind of sentence children understand, which may be the more rigorous product requirement.
Attention, reassigned
Galán's career resists the flattering fiction that good lives move upward in one continuous line. He left medicine near the credential. He built a company around the defect that pushed him away. That company grew, raised capital, installed hardware across the country, and closed. Then he left the identity of founder behind and organized his days around two children.
The connective tissue is not ambition in its familiar, acquisitive sense. It is attention. Who gets it? What steals it? Which systems deserve it, and which merely demand it? Robin tried to return attention to the exam room. Full-time parenthood redirected Galán's own toward home.
In an earlier interview, he said he believed healthcare's story was closer to the middle than the end. The same is plainly true of his. A person who has already abandoned two prestigious identities should not be expected to settle for a neat final paragraph. For now, the former medical student and former CEO is doing work whose metrics arrive without dashboards: school days, ordinary moments, a stroller moving forward.